These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 14672629)

  • 1. Magnetic resonance imaging of liver tumors.
    Lencioni R; Cioni D; Crocetti L; Della Pina C; Bartolozzi C
    J Hepatol; 2004 Jan; 40(1):162-71. PubMed ID: 14672629
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast-enhanced magnetic resonance imaging of the liver.
    Van Beers B
    J Belge Radiol; 1997 Dec; 80(6):322. PubMed ID: 9479919
    [No Abstract]   [Full Text] [Related]  

  • 3. [Super-paramagnetic iron oxide: an MRI contrast media for the reticuloendothelial system].
    Gandon Y; Brunet F; Guyader D; Brissot P; Carsin M; Simon J
    Ann Radiol (Paris); 1989; 32(4):267-72. PubMed ID: 2554776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocyte-specific magnetic resonance imaging contrast agents.
    Fidler J; Hough D
    Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
    [No Abstract]   [Full Text] [Related]  

  • 5. Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.
    Chou CT; Chen YL; Su WW; Wu HK; Chen RC
    J Magn Reson Imaging; 2010 Oct; 32(4):895-902. PubMed ID: 20882620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chondroitin sulfate iron colloid as an MR contrast agent for the hepatic reticuloendothelial system.
    Kato T; Suto Y; Matsuo T
    J Comput Assist Tomogr; 1993; 17(4):603-8. PubMed ID: 8392526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the tolerance dose of the hepatic reticulo-endothelial system (RES) after single fraction HDR-irradiation: an in-vivo study employing SSPIO.
    Pech M; Ricke J; Seidensticker M; Staskiewicz G; Wieners G; Mohnike K; Ruhl R; Steinberg J; Wust P; Seidensticker P
    Int J Radiat Biol; 2008 Oct; 84(10):830-7. PubMed ID: 18979318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal nodular hyperplasia of the liver: usefulness of superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Okada T; Sasaki F; Kamiyama T; Nakagawa T; Nakanishi K; Kobayashi R; Itoh T; Ota S; Todo S
    J Pediatr Surg; 2005 Mar; 40(3):E21-5. PubMed ID: 15793708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential diagnosis of intra- and perilienal tumors by use of a RES-specific MRI contrast agent].
    Gaffke G; Stroszczynski C; Gnauck M; Jost D; Chmelik P; Ludwig WD; Gretschel S; Felix R
    Rontgenpraxis; 2004; 55(5):192-9. PubMed ID: 15700656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hepatocyte-specific contrast agents in hepatobiliary magnetic resonance imaging.
    Burke C; Alexander Grant L; Goh V; Griffin N
    Semin Ultrasound CT MR; 2013 Feb; 34(1):44-53. PubMed ID: 23395317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging of liver malignancies.
    Ba-Ssalamah A; Fakhrai N; Matzek WK; Herneth AM; Stadler A; Bastati N; Herold CJ; Schima W
    Top Magn Reson Imaging; 2007 Dec; 18(6):445-55. PubMed ID: 18303402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic criteria for hepatocellular carcinoma ⩽3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging.
    Choi SH; Byun JH; Lim YS; Yu E; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
    J Hepatol; 2016 May; 64(5):1099-1107. PubMed ID: 26820629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early hepatocellular carcinomas showing isointensity or hyperintensity in gadoxetic acid-enhanced, hepatocyte-phase magnetic resonance images.
    Chen N; Motosugi U; Sano K; Ichikawa T; Nakano M; Morisaka H; Ichikawa S; Matsuda M; Fujii H; Enomoto N; Araki T
    J Comput Assist Tomogr; 2013; 37(3):466-9. PubMed ID: 23674023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast agents used in MR imaging of the liver.
    Karabulut N; Elmas N
    Diagn Interv Radiol; 2006 Mar; 12(1):22-30. PubMed ID: 16538580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contrast agents for magnetic resonance imaging of the liver.
    Josephson L; Groman E; Weissleder R
    Targeted Diagn Ther; 1991; 4():163-87. PubMed ID: 1797156
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic resonance imaging of liver neoplasms.
    Saini S; Ferrucci JT
    Prog Liver Dis; 1990; 9():625-42. PubMed ID: 2156318
    [No Abstract]   [Full Text] [Related]  

  • 17. Liver: enhancing tumors and vascular obstructions.
    Mitchell DG
    Diagn Imaging (San Franc); 1993; 15 Suppl():2-7. PubMed ID: 10148785
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progress in magnetic resonance tomography of the liver: value of ultra-rapid imaging and liver-specific contrast media].
    Reimer P; Rummeny EJ; Hamm B; Mühler A; Cavagna F; Saini S; Peters PE
    Bildgebung; 1994 Mar; 61(1):5-13. PubMed ID: 8193519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced MR imaging of the liver.
    Saini S
    Radiology; 1992 Jan; 182(1):12-4. PubMed ID: 1727273
    [No Abstract]   [Full Text] [Related]  

  • 20. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
    Fowler KJ; Brown JJ; Narra VR
    Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.